Search Results

Adi Nagler

Dr. Adi Nagler received her Ph.D. at the Weizmann Institute of Science in , under the mentorship of Prof. Yardena Samuels.

Julia Paczkowska

Dr. Julia Paczkowska completed her master’s degree in pharmacy at Poznan University of Medical Science, Poland.

Characterization and Targeting of Tumor-Associated Monocytes/ Macrophages that Limit the Efficacy of PD-1 Blockade in Lymphoma

Inhibition of the exhaustion pathway enables the immune system to attack cancers. blockade is now a standard treatment for relapsed classic Hodgkin …

Mechanisms of Clonal Evolution in the Transformation of MPN to sAML

This research will investigate blood stem cell mutations associated with progression of myeloproliferative neoplasm (MPN) to secondary acute myeloid l…

Tyler Parsons

Dr. Tyler Parsons completed his PhD research at Oakland University and the Beaumont Research Institute in the lab of Dr. Gerard Madlambayan where he p…

Elucidating the role of FAM72A in EBV-driven B cell lymphomagenesis

This work focuses on characterizing the role of FAM72A in B cell tumorigenesis. This protein is upregulated by EBV during the transformation of B cel…

Jessica Stewart

I am a college graduate with a Master’s degree in Chemistry and Ph.D. in Biochemistry. My career goal is to lead my own research group focused on un…

The LLS National Patient Registry: COVID-19 Studies

Suggested Reading - Paisley’s Pay it Forward Adventure

Analysis and Targeting of Tumor-Associated Monocytes/Macrophages that Inhibit PD-1 Blockade

Inhibition of a immune exhaustion pathway, termed blockade, enables immune effector cells to attack cancers. In classic Hodgkin Lymphoma (cHL), blo…

Matthew Frank

I am a and an Assistant Professor of Medicine in the Division of Blood and Marrow Transplantation and Cellular Therapy (BMT&CT). Clinically, I care f…

Autologous CD22 CAR T cell Therapy for the Treatment of non-Hodgkin Lymphoma

CD19 targeting chimeric antigen receptor (CAR) T cell therapies (CAR19) are effective treatments for patients with Lymphoma (NHL), however, the major…

Fecal microbiota transplantation to prevent acute GVHD after allogeneic stem cell transplantation

In up to half of patients with hematologic malignancies undergoing allogeneic stem cell transplantation, the trajectory of a smooth recovery toward cu…

Steven Treon

Steve Treon MD, PhD is a Senior Physician and the Director of the Bing Center for Waldenstrom’s Macroglobuliemia (WM) at the Dana Farber Cancer Instit…

Targeting mutated MYD88 pro-survival signaling in B-cell malignancies

Our laboratory and those of others discovered highly recurring mutations in the gene MYD88 which are found in patients with various cancers including…

Pharmacological strategies to enhance T- and NK-cell-based therapies in blood cancers

Although they represent a major therapeutic progress for blood cancers, cells and other based therapies are subject to eventual development of resis…

The Impossible Choice: The Role of Insurance Design on Financial Toxicity and Access to Care for Individuals with Blood Cancer

The overall goal of this project is to understand the role of insurance design on financial toxicity and access to care among individuals with blood c…

Towards Equity in Specialized Cancer Care for Adolescents and Young Adults with Newly Diagnosed Acute Lymphoblastic Leukemia

Our study is designed to directly inform the pathways through which health insurance influences access to care at an SCC for individuals with AYA ALL …